Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

Abstract

The present application discloses novel 8-aza-bicyclo[3.2.1]oct-3-yloxy)-chromen-2-one derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the application discloses the use of these compounds, a method for therapy and to pharmaceutical compositions comprising these compounds.

Dependencies are inferred from the claim text.